Expression And Prognostic Value Of CD44 Isoforms In Nephroblastoma (Wilms Tumor)
- 1 August 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (2) , 681-686
- https://doi.org/10.1016/s0022-5347(05)64723-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CD44 IS AN INDEPENDENT PROGNOSTIC FACTOR IN CONVENTIONAL RENAL CELL CARCINOMASJournal of Urology, 1999
- High‐level Expression of the CD44 Variant Sharing Exon v10 in Renal CancerJapanese Journal of Cancer Research, 1995
- Expressions of E-Cadherin and Exon V6-Containing Isoforms of CD44 and their Prognostic Values in Human Transitional Cell CarcinomaJournal of Urology, 1995
- Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteinsThe Lancet, 1994
- CD44 splice variants: metastases meet lymphocytesImmunology Today, 1993
- CD44 and cancer screeningThe Lancet, 1993
- Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular originThe Journal of cell biology, 1993
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.The Journal of Experimental Medicine, 1993
- Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancyJournal of Cellular Biochemistry, 1993
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991